Abstract
Proteomics is one of the emerging techniques for biomarker discovery. Biomarkers can be used for early noninvasive diagnosis and prognosis of diseases and treatment efficacy evaluation. In the present study, the well-established research systems of ClinProt Micro solution incorporated unique magnetic bead sample preparation technology, which, based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), have become very successful in bioinformatics due to its outstanding performance and reproducibility for discovery disease-related biomarker. We collected fasting blood samples from patients with biopsy-confirmed acute renal allograft rejection (n = 12), chronic rejection (n = 12), stable graft function (n = 12) and also from healthy volunteers (n = 13) to study serum peptidome patterns. Specimens were purified with magnetic bead–based weak cation exchange chromatography and analyzed with a MALDI-TOF mass spectrometer. The results indicated that 18 differential peptide peaks were selected as potential biomarkers of acute renal allograft rejection, and 6 differential peptide peaks were selected as potential biomarkers of chronic rejection. A Quick Classifier Algorithm was used to set up the classification models for acute and chronic renal allograft rejection. The algorithm models recognize 82.64% of acute rejection and 98.96% of chronic rejection episodes, respectively. We were able to identify serum protein fingerprints in small sample sizes of recipients with renal allograft rejection and establish the models for diagnosis of renal allograft rejection. This preliminary study demonstrated that proteomics is an emerging tool for early diagnosis of renal allograft rejection and helps us to better understand the pathogenesis of disease process.
Similar content being viewed by others
References
Cecka JM (2005) The OPTN/UNOS renal transplant registry. Clin Transpl 1–16 (PubMed: 17424721)
Allen RDM, Chapman JR (1994) A manual of renal transplantation. Little Brown, Boston
Wilczek HE (1990) Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies. Transplantation 50(5):790–797 (PubMed:2238054)
Kolb LG, Velosa JA, Bergstralh EJ, Offord KP (1994) Percutaneous renal allograft biopsy. A comparison of two needle types and analysis of risk factors. Transplantation 57(12):1742–1745 (PubMed: 80168879)
Roberti I, Reisman L (2001) Serial evaluation of cell surface markers for immune activation after acute renal allograft rejection by urine flow cytometry: correlation with clinical outcome. Transplantation 71(9):1317–1320 (PubMed: 11397970)
Woodle ES, Cronin D, Newell KA, Millis JM, Bruce DS, Piper JB et al (1996) Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation 62(7):906–910 (PubMed: 8878382)
Beckingham IJ, Nicholson ML, Bell PR (1994) Analysis of factors associated complications following renal transplant needle core biopsy. Br J Urol 73(1):13–15 (PubMed: 8298893)
Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K et al (2009) Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Clin Cancer Res 15(11):3812–3819 (PubMed:19470732)
Schaub NP, Jones KJ, Nyalwidhe JO, Cazares LH, Karbassi ID, Semmes OJ et al (2009) Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients. J Am Coll Surg 208(5):970–978 (PubMed:19476873)
Hinkelbein J, Feldmann RE Jr, Schubert C, Peterka A, Schelshorn D, Maurer MH et al (2009) Alterations in rat serum proteome and metabolome as putative disease markers in sepsis. J Trauma 66(4):1065–1075 (PubMed:19359916)
Pandey A, Mann M (2000) Proteomics to study genes and genomes. Nature 405(6788):837–846 (PubMed: 10866210)
Gilar M, Olivova P, Chakraborty AB, Jaworski A, Geromanos SJ, Gebler JC (2009) Comparison of 1-D and 2-D LC MS/MS methods for proteomic analysis of human serum. Electrophoresis 30(7):1157–1167 (PubMed:19283699)
Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK et al (2009) Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J Proteome Res 8(3):1565–1576 (PubMed:19199705)
Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M et al (2008) Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 8(4):753–760 (PubMed: 18294345)
Ketterlinus R, Hsieh SY, Teng SH, Lee H, Pusch W (2005) Fishing for biomarkers: analyzing mass spectrometry data with the new ClinPro Tools software. Biotechniques 38:37–40 (PubMed: 16528916)
Kirk AD (2002) Location, location, location: regional immune mechanisms critically influence rejection. Nat Med 8(6):553–555 (PubMed: 12042797)
Qi F, Adair A, Ferenbach D, Vass DG, Mylonas KJ, Kipari T et al (2008) Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 86(9):1267–1274 (PubMed: 19005409)
Fu Y, Yi S, Wu J, Jimenez E, Simond D, Hawthorne WJ et al (2008) In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+ CD25+ regulatory T cells. Transplantation 86(6):865–874 (PubMed:18813112)
Lin ML, Zhan Y, Nutt SL, Brady J, Wojtasiak M, Brooks AG et al (2006) NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism. Xenotransplantation 13(6):536–546 (PubMed: 17059581)
Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J et al (2008) Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 85(11):1557–1563 (PubMed: 18551059)
Péfaur J, Díaz P, Panace R, Salinas P, Fiabane A, Quinteros N et al (2008) Early and late humoral rejection: a clinicopathologic entity in two times. Transplant Proc 40(9):3229–3236 (PubMed: 19010241)
Yang YW, Lin WC, Wu MS, Lee PH, Tsai MK (2008) Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant. Exp Clin Transplant 6(3):211–214 (PubMed: 18954299)
Cruzado JM, Bestard O, Grinyó JM (2009) Control of anti-donor antibody production post-transplantation: conventional and novel immunosuppressive therapies. Contrib Nephrol 162:117–128 (PubMed: 19001819)
Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C et al (2009) Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 162:1–12 (PubMed 09001809)
Elmagd MM, Bakr MA, Metwally AH, Wahab AM (2008) Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant. Exp Clin Transplant 6(1):42–47 (PubMed: 18405244)
Nwankwo EA, Bakari AA, Ene AC (2008) Post transplantation diabetes mellitus in kidney allograft recipients: Current concepts. Saudi J Kidney Dis Transpl 19(6):904–910 (PubMed: 18974574)
Fernández-Fresnedo G, Gómez-Alamillo C, Ruiz JC, de Francisco AL, Arias M (2009) Chronic renal disease in renal transplant patients: management of cardiovascular risk factors. Transplant Proc 41(5):1637–1638 (PubMed:19545697)
Paoletti E, Gherzi M, Amidone M, Massarino F, Cannella G (2009) Association of arterial hypertension with renal target organ damage in kidney transplant recipients: the predictive role of ambulatory blood pressure monitoring. Transplantation 87(12):1864–1869 (PubMed 19543066)
Díaz Gómez JM (2008) Cardiovascular mortality in kidney transplantation. Nefrologia 28(5):27–30 (PubMed: 18847417)
Aalten J, Hoogeveen EK, Roodnat JI, Weimar W, Borm GF, de Fijter JW et al (2008) Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 21(10):985–991 (PubMed: 18564985)
Sharifipour F, Rezaeetalab F, Naghibi M (2009) Pulmonary fungal infections in kidney transplant recipients: an 8-year study. Transplant Proc 41(5):1654–1656 (PubMed:19545701)
Linares L, Cervera C, Cofán F, Lizaso D, Marco F, Ricart MJ et al (2008) Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 8(5):1000–1005 (PubMed: 18727176)
Khameneh ZR (2008) Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study. Saudi J Kidney Dis Transpl 19(1):41–45 (PubMed: 18087121)
Végso G, Járay J (2007) Malignant tumors following renal transplantation. Orv Hetil 148(45):2115–2123 (PubMed: 17984022)
Donia AF, Mostafa A, Refaie H, El-Baz M, Kamal MM, Ghoneim MA (2008) Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience. Transplantation 86(8):1139–1142 (PubMed: 18946354)
Falsarella PM, Alves-Filho G, Mazzali M (2008) Skin malignancies in renal transplant recipients: a Brazilian center registry. Transplant Proc 40(3):767–768 (PubMed: 18455011)
Huang Z, Shi Y, Cai B, Wang L, Wu Y, Ying B et al (2009) MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus. Rheumatology (Oxford) 48(6):626–631 (PubMed:19389822)
Alagaratnam S, Mertens BJ, Dalebout JC, Deelder AM, van Ommen GJ, den Dunnen JT et al (2008) Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 8(8):1552–1563 (PubMed: 18409166)
Navare A, Zhou M, McDonald J, Noriega FG, Sullards MC, Fernandez FM (2008) Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 22(7):997–1008 (PubMed: 18320548)
Kobayashi CA, Leite AL, Silva TL, Santos LD, Nogueira FC, Oliveira RC et al (2009) Proteomic analysis of kidney in rats chronically exposed to fluoride. Chem Biol Interact 180(2):305–311 (PubMed:19497429)
Dai Y, Lv T, Wang K, Huang Y, Li D, Liu J (2008) Detection of acute renal allograft rejection by analysis of renal tissue proteomics in rat models of renal transplantation. Saudi J Kidney Dis Transpl 19(6):952–959 (PubMed: 18974583)
Wannemacher KM, Terskiy A, Bian S, Yadav PN, Li H, Howells RD (2008) Purification and mass spectrometric analysis of the kappa opioid receptor. Brain Res 1230:13–26 (PubMed: 18656460)
Yu M, Wang X, Du Y, Chen H, Guo X, Xia L et al (2008) Comparative analysis of renal protein expression in spontaneously hypertensive rat. Clin Exp Hypertens 30(5):315–325 (PubMed: 18633755)
O’Riordan E, Orlova TN, Mei JJ, Butt K, Chander PM, Rahman S et al (2004) Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 15(12):3240–3248 (PubMed: 15579528)
Quintana LF, Solé-Gonzalez A, Kalko SG, Bañon-Maneus E, Solé M, Diekmann F et al (2009) Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 20(2):428–435 (PubMed: 19056874)
Wang JN, Zhou Y, Zhu TY, Wang X, Guo YL (2008) Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS. J Proteome Res 7(8):3597–3601 (PubMed: 18620448)
Conflict of interest
No financial relationship exists between any of the authors and any commercial interest with a vested interest in the outcome of the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sui, W., Huang, L., Dai, Y. et al. Proteomic profiling of renal allograft rejection in serum using magnetic bead–based sample fractionation and MALDI-TOF MS. Clin Exp Med 10, 259–268 (2010). https://doi.org/10.1007/s10238-010-0094-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-010-0094-5